Mirabegron is used is in the treatment of overactive bladder. It is sold under the brand name Myrbetriq. Reference standards of Mirabegron API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(R)-2-(2-Aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)(nitroso)amino)ethyl)phenyl)-N-nitrosoacetamide
Catalogue No.:PA 13 0811044
CAS :
Molecular Formula : C21H22N6O4S
Molecular Weight : 454.51
N-Nitroso Mirabegron D5
Catalogue No.:PA STI 089694
Molecular Formula : C21H18D5N5O3S
Molecular Weight : 430.54
N-(4-Aminophenethyl)-N-(2-hydroxy-2-phenylethyl)nitrous amide
Catalogue No.:PA 13 0811045
Molecular Formula : C16H19N3O2
Molecular Weight : 285.35
Ethyl 2-(2-aminothiazol-4-yl)acetate
Catalogue No.:PA 13 0811046
Molecular Formula : C7H10N2O2S
Molecular Weight : 186.23
N-[2-(4-Amino-phenyl)-ethyl]-2-(2-amino-thiazol-4-yl)-N-(2-hydroxy-2-phenyl-ethyl)-acetamide
Catalogue No.:PA 13 0811047
Molecular Formula : C21H24N4O2S
Molecular Weight : 396.51
N-(4-Aminophenethyl)acetamide
Catalogue No.:PA 13 0811048
Molecular Formula : C10H14N2O
Molecular Weight : 178.24
(S)-2-((2-Nitrophenethyl)amino)-1-phenylethan-1-ol
Catalogue No.:PA 13 0811049
Molecular Formula : C16H18N2O3
Molecular Weight : 286.33
N-(2-Nitrophenethyl)acetamide
Catalogue No.:PA 13 0811050
Molecular Formula : C10H12N2O3
Molecular Weight : 208.22
2-(2-Aminothiazol-4-yl)-N-(4-(2-((2R,5R)-2-hydroxy-5-phenyloxazolidin-3-yl)ethyl)phenyl)acetamide compound with 2-(2-Aminothiazol-4-yl)-N-(4-(2-((2S,5R)-2-hydroxy-5-phenyloxazolidin-3-yl)ethyl)phenyl)acetamide (1:1)
Catalogue No.:PA 13 0811051
Molecular Formula : C22H24N4O3S
Molecular Weight : 424.52
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
